Class information for:
Level 1: PARP INHIBITORS//OLAPARIB//BRCANESS

Basic class information
Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY 2934640
120 3       DNA REPAIR//BRCA1//BRCA2 70548
236 2             BRCA1//BRCA2//FANCONI ANEMIA 19966
8223 1                   PARP INHIBITORS//OLAPARIB//BRCANESS 1304

Terms with highest relevance score


rank Category termType chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 PARP INHIBITORS authKW 2593367 16% 53% 203
2 OLAPARIB authKW 1879249 7% 80% 97
3 BRCANESS authKW 645134 2% 86% 31
4 VELIPARIB authKW 503366 2% 77% 27
5 SYNTHETIC LETHALITY authKW 347207 5% 22% 65
6 HOMOLOGOUS RECOMBINATION DEFICIENCY authKW 339856 1% 94% 15
7 RUCAPARIB authKW 291737 1% 93% 13
8 ABT 888 authKW 271879 1% 75% 15
9 PARP INHIBITION authKW 244193 2% 42% 24
10 PARP1 authKW 204175 3% 23% 37

Web of Science journal categories


chi_square_rank Category chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 Oncology 21332 66% 0% 855
2 Cell Biology 498 12% 0% 154
3 Obstetrics & Gynecology 345 6% 0% 74
4 Chemistry, Medicinal 309 5% 0% 69
5 Pharmacology & Pharmacy 252 11% 0% 138
6 Pathology 83 3% 0% 38
7 Medicine, Research & Experimental 45 3% 0% 45
8 Biochemistry & Molecular Biology 40 10% 0% 125
9 Genetics & Heredity 33 4% 0% 47
10 Radiology, Nuclear Medicine & Medical Imaging 21 3% 0% 38

Address terms


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 MED ONCOLMED GYNECOL ONCOL PROGRAM 120838 0% 100% 5
2 CRUK GENE FUNCT 85101 1% 39% 9
3 BREAKTHROUGH BREAST CANC 58126 3% 6% 41
4 DRUG DEV UNIT 58071 2% 10% 23
5 EXPT PRECLIN 54376 0% 75% 3
6 PL DEV SUPPORT DIRECTORATE 40273 0% 33% 5
7 NO CANC 39927 2% 6% 30
8 CLIN TARGET VALIDAT 39463 1% 23% 7
9 BCOH EA4340 32222 0% 67% 2
10 CHEMOTHER Y CLIN CANC 32222 0% 67% 2

Journals


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 CLINICAL CANCER RESEARCH 10041 6% 1% 80
2 CANCER DISCOVERY 7829 1% 3% 13
3 HEREDITARY CANCER IN CLINICAL PRACTICE 6252 1% 4% 7
4 MOLECULAR CANCER THERAPEUTICS 6219 3% 1% 33
5 NATURE REVIEWS CLINICAL ONCOLOGY 3261 1% 2% 8
6 ONCOTARGET 3072 4% 0% 46
7 BREAST CANCER RESEARCH 2735 1% 1% 16
8 ANNALS OF ONCOLOGY 2697 2% 0% 31
9 MOLECULAR CANCER RESEARCH 2388 1% 1% 14
10 GYNECOLOGIC ONCOLOGY 2370 3% 0% 34

Author Key Words


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass LCSH search Wikipedia search
1 PARP INHIBITORS 2593367 16% 53% 203 Search PARP+INHIBITORS Search PARP+INHIBITORS
2 OLAPARIB 1879249 7% 80% 97 Search OLAPARIB Search OLAPARIB
3 BRCANESS 645134 2% 86% 31 Search BRCANESS Search BRCANESS
4 VELIPARIB 503366 2% 77% 27 Search VELIPARIB Search VELIPARIB
5 SYNTHETIC LETHALITY 347207 5% 22% 65 Search SYNTHETIC+LETHALITY Search SYNTHETIC+LETHALITY
6 HOMOLOGOUS RECOMBINATION DEFICIENCY 339856 1% 94% 15 Search HOMOLOGOUS+RECOMBINATION+DEFICIENCY Search HOMOLOGOUS+RECOMBINATION+DEFICIENCY
7 RUCAPARIB 291737 1% 93% 13 Search RUCAPARIB Search RUCAPARIB
8 ABT 888 271879 1% 75% 15 Search ABT+888 Search ABT+888
9 PARP INHIBITION 244193 2% 42% 24 Search PARP+INHIBITION Search PARP+INHIBITION
10 PARP1 204175 3% 23% 37 Search PARP1 Search PARP1

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.

Classes with closest relation at Level 1


rank cluster_id2 link
1 512 POLYADP RIBOSE POLYMERASE//POLYADP RIBOSE//POLYADP RIBOSYLATION
2 5866 BRCA1//BARD1//BRCA2
3 9427 TRIPLE NEGATIVE BREAST CANCER//TRIPLE NEGATIVE//BASAL LIKE
4 30725 TANKYRASE//TANKYRASE 1//TANKYRASE INHIBITORS
5 30131 PERITONEAL TUMOR SPREAD//AUTOMATED CLASS DISCOVERY//CELL LINE MODEL FOR SUBTYPE
6 425 BRCA2//BRCA1//HEREDITARY BREAST CANCER
7 14959 BEVACIZUMAB//OVARIAN CANCER//GYNECOL ONCOL
8 15784 CHEK2//PALB2//CHK2
9 5007 GAMMA H2AX//53BP1//H2AX
10 21842 RESEARCH BIOPSY//PRECISION ONCOLOGY//PERSONALIZED CANC THER Y

Go to start page